| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Net income | 1,836 | 14,491 | 17,079 | 128,634 |
| Gain on sale of business | 0 | 0 | 0 | 176,162 |
| Impairment of goodwill, fixed assets and other intangibles | 1,839 | 0 | 0 | 25,114 |
| Unrealized losses on equity investments | 0 | 0 | 0 | 28,077 |
| Depreciation and amortization | 12,342 | 12,912 | 12,091 | 27,258 |
| Non-cash lease expense | 6,451 | 6,743 | 6,429 | 13,055 |
| Stock-based compensation | 3,695 | 3,160 | 5,819 | 15,126 |
| Inventory write-down | 4,750 | -2,036 | 43 | 5,800 |
| Foreign currency losses (gains) | 1,387 | -1,624 | -2,027 | -2,441 |
| Loss on disposal of assets | -303 | 11 | -243 | 72 |
| Deferred taxes | -1,723 | -8,174 | 1,361 | 6,793 |
| Accounts receivable, net | 5,737 | -8,737 | -9,978 | 8,660 |
| Inventories, net | 5,882 | -884 | -94 | -10,909 |
| Prepaid expenses and other | 9,138 | 21,977 | 4,689 | -6,251 |
| Other assets | -199 | -931 | 2,152 | 7,356 |
| Accounts payable | 2,750 | -2,247 | -41 | -6,824 |
| Accrued expenses | -14,696 | -13,191 | -20,790 | -20,334 |
| Other liabilities | -2,967 | -1,573 | 2,711 | -280 |
| Net cash (used in) provided by operating activities | -3,919 | 16,621 | 27,481 | 36,184 |
| Purchases of property and equipment | 13,714 | 10,760 | 9,915 | 13,602 |
| Purchases of investments | 573 | 0 | 0 | 0 |
| Acquisitions (net of cash acquired) | NaN | 0 | NaN | NaN |
| Proceeds on investment sales | 0 | 0 | 0 | 10,214 |
| Proceeds from sale of business, net | 0 | 0 | 0 | 193,725 |
| Other, net | NaN | -1,000 | NaN | NaN |
| Net cash (used in) provided by investing activities | -14,287 | -9,760 | -9,915 | 190,337 |
| Exercise of employee stock options and taxes paid related to the net shares settlement of stock awards | -4,157 | -741 | -29 | -1,142 |
| Payment of cash dividends | 2,873 | 2,906 | 2,962 | 5,966 |
| Repurchases of shares of common stock | 5,011 | 10,020 | 5,008 | 5,012 |
| Contingent consideration payments | NaN | 0 | 0 | 0 |
| Other, net | NaN | 649 | 1,758 | 1,213 |
| Finance lease principal payments | 489 | 483 | 635 | 1,120 |
| Proceeds from debt | 225,000 | 0 | 40,000 | 15,000 |
| Payments of debt | 225,000 | 5,000 | 60,000 | 160,000 |
| Payment of debt issuance costs | 1,369 | NaN | NaN | NaN |
| Purchase of noncontrolling interest | 6,500 | NaN | NaN | NaN |
| Net cash used in financing activities | -20,399 | -18,501 | -26,876 | -157,027 |
| Effect of exchange rate changes on cash | -1,371 | -1,517 | -3,062 | 7,782 |
| Net (decrease) increase in cash and cash equivalents | -39,976 | -13,157 | -12,372 | 77,276 |
| Cash and cash equivalents, beginning of period | 238,630 | 251,787 | 186,883 | NaN |
| Cash and cash equivalents, end of period | 198,654 | 238,630 | 251,787 | NaN |
NU SKIN ENTERPRISES, INC. (NUS)
NU SKIN ENTERPRISES, INC. (NUS)